Send to

Choose Destination
J Infect Dis. 1995 Oct;172(4):988-92.

Inhibition of toxic shock syndrome toxin-1-induced cytokine production and T cell activation by interleukin-10, interleukin-4, and dexamethasone.

Author information

Applied Research Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland 21702-5011, USA.


Toxic shock syndrome toxin-1 (TSST-1) induced production of the cytokines tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-1, IL-6, IL-2, and interferon-gamma (IFN-gamma) by human peripheral blood mononuclear cells (PBMC). In contrast, only low levels of IL-10 were present and IL-4 was absent in TSST-1-stimulated PBMC. Addition of IL-10 to TSST-1-stimulated PBMC inhibited the production of TNF-alpha, IL-1, IL-6, and IFN-gamma by 68%, 93%, 70%, and 86%, respectively, but had less effect (14%-37%) on T cell proliferation. IL-4 was less effective than IL-10 in inhibiting cytokine production and had no effect on T cell proliferation induced by TSST-1. Dexamethasone, an antiinflammatory agent, was the most potent agent in controlling TSST-1-mediated effects, as evidenced by inhibited T cell proliferation (> 74%), reduced levels of cytokines (70%-84%), and reduced expression of CD25 and CD69 on PBMC. Thus, dexamethasone may be a useful agent to mitigate TSST-1-mediated toxic shock.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center